NOXXON Pharma AG appoints Dr. Aram Mangasarian as Chief Business Officer

19-May-2010 - Germany

NOXXON Pharma AG announced the appointment of Dr. Aram Mangasarian as Chief Business Officer and Member of the Executive Committee. Dr. Mangasarian will be responsible for corporate and business development activities for NOXXON.

Dr. Mangasarian brings to NOXXON more than 10 years of business development and strategic planning experience within the biotechnology and pharmaceutical industry. He joins NOXXON from Novexel, a French venture-funded anti-infectives company, which was recently acquired by AstraZeneca, where he held the position of Vice President of Business Development. Prior to Novexel, Dr. Mangasarian served as Vice President of Business Development at ExonHit Therapeutics. As graduate of the University of California, San Diego, Dr. Mangasarian earned his PhD in the Department of Biology by conducting research on HIV. He also holds an MBA from INSEAD. In his career he has successfully negotiated licensing transactions and strategic alliances with major pharmaceutical companies.

Other news from the department people

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics